# Prospective Study on the Efficacy and Safety of Bronchoalveolar Lavage Combined With Pathogen Metagenomic Sequencing Technology in the Diagnosis of Immune Checkpoint Inhibitor Associated Pneumonia

> **NCT06192303** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 104 (estimated)

## Conditions studied

- Immune Checkpoint Inhibitor Associated Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** Bronchoalveolar lavage and pathogen metagenomic sequencing

## Key facts

- **NCT ID:** NCT06192303
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06192303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06192303, "Prospective Study on the Efficacy and Safety of Bronchoalveolar Lavage Combined With Pathogen Metagenomic Sequencing Technology in the Diagnosis of Immune Checkpoint Inhibitor Associated Pneumonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06192303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*